Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Phase 2 Trial of Retatrutide for Obesity NEJM summary
Use in pregnancy or breastfeeding requires medical consultation, as the medicines effects in these stages are not fully established and the doctor may advise stopping or switching based on the situation
Whilst lifestyle modifications such as increased hydration and dietary fibre are first-line measures, stool softeners and laxatives may be necessary for effective symptom relief
324 More recently, the drug has been approved for phase II/III clinical experiments showing good effectiveness and safety (NCT04145531) (Tables 1, 2)
US$ 21.72
US$ 21.62
US$ 26.45
US$ 21.01
